Jaime Simon

Fundador en IGL Pharma, Inc. .

Health Services

Health Technology

Perfil

Jaime Simon is the founder of IGL Pharma, Inc. where he holds the title of Director since 2016.
He is also the founder of IsoTherapeutics Group LLC, where he holds the title of Chief Scientific Officer & Vice President since 2005.

Cargos activos de Jaime Simon

Empresas	Cargo	Inicio
IGL Pharma, Inc. IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX.	Fundador	01/01/2016
IsoTherapeutics Group LLC IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million.	Fundador	01/01/2005

Todos los cargos activos de Jaime Simon

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jaime Simon.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
IGL Pharma, Inc. IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX.	Health Services
IsoTherapeutics Group LLC IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million.	Health Technology